Solvency II has been an integral part of the European regulatory landscape for several years now. The timing of Solvency II reporting requirements remains a challenge for many (re)insurers, particularly in the context of a busy reporting and regulatory agenda and the current COVID-19 environment.
As the IFRS 17 start date nears and work continues to implement the necessary processes, it is essential to keep in mind the key IFRS 17 milestones and developments having implications for insurance companies.
This document highlights the key timelines for insurers for Solvency II and IFRS, as well as other important dates. It suggests key areas for consideration to help companies understand the implications for their organisation.